Questions across 2 calls

Rishi Mody

RDM Advisory LLP

Dr. Lal Path Labs Ltd.

Dr. Lal Path Labs Ltd. CC-May26.pdf · 2026-04-30

Shankha, just wanted to get your understanding on Suburban. You mentioned that a large part of the growth contributor has been Suburban. I understand one would be that operations normalized after that software update that you all were talking about. There would be a portion of lost revenue, which is still normal. But beyond that also, is there growth which has come from either market share gains or like what has led to that, if there is significant growth from that piece as well?

All right. So could you just help me with the numbers for Suburban revenue like this quarter v/s Q3 and say, last year Q4? So I just get an idea of what runway to expect for FY27 on Suburban?

Tata Elxsi Limited

Tata Elxsi Limited CC-Apr26.pdf · 2026-04-21

Yes, hi. So my first question is pertaining to the quarterly result. So healthcare, we've declined 13% Q-o-Q on constant currency in our revenue. Last quarter, you called out that probably Q3 was the bottom. Just wanted to get your view that do we see Q4 as now the bottom or is there something which has changed over the past three months for us there?

Got it. So say Q1 plus Q4 combined should have positive growth over Q2 and Q3 if that's how I have to look at it. Second, on the USA business, the media and communications industry, the consolidation seems to have happened. Are we now going to go back on the higher growth trajectory here, or is there something which needs to be recalibrated in USA a nd the media and communication both, sorry?